4-hydroxynonenal regulates mitochondrial function in human small airway epithelial cells

Area of Science:

• Cellular and Molecular Biology
• Pulmonary Medicine
• Toxicology

Background:

• Oxidative stress and mitochondrial dysfunction are key in hyperoxic Acute Lung Injury (ALI).
• The toxic molecule 4-hydroxynonenal (4-HNE) is produced during hyperoxia, but its precise role in mitochondrial damage is unclear.
• Previous in vivo studies indicated increased 4-HNE-protein adducts and MDA levels in hyperoxic lungs.

Purpose of the Study:

• To investigate the effects of 4-hydroxynonenal (4-HNE) on human small airway epithelial cells (SAECs).
• To elucidate the mechanisms by which 4-HNE disrupts cellular and mitochondrial function.
• To assess the impact of 4-HNE on the endogenous antioxidant response in SAECs.

Main Methods:

• Human SAECs were treated with 25 μM of 4-HNE.
• Assessed cellular viability, caspase-3 activity, ATP levels, mitochondrial membrane potential, and aconitase activity.
• Measured mitochondrial oxygen consumption, reserve capacity, and Thioredoxin (Trx) protein levels and activity.

Main Results:

• 4-HNE treatment significantly decreased SAEC viability and increased caspase-3 activity.
• Impaired mitochondrial function was observed, including reduced ATP production, mitochondrial membrane potential, and aconitase activity.
• 4-HNE led to decreased oxygen consumption, depleted reserve capacity, and time-dependent depletion of Trx proteins and activity.

Conclusions:

• 4-hydroxynonenal (4-HNE) induces significant cellular and mitochondrial dysfunction in human SAECs.
• The observed dysfunction includes impaired energy production and compromised antioxidant defenses.
• These findings highlight 4-HNE as a critical mediator of lung cell injury in oxidative stress conditions.